Turkiye Sinai Kalkinma Bankasi AS
IST:TSKB.E
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.09
14.53
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TRY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Turkiye Sinai Kalkinma Bankasi AS
Türkiye Sinai Kalkinma Bankasi AS engages in the provision of corporate, investment and advisory services. The company is headquartered in Istanbul, Istanbul Province. The service range covers corporate lending and project finance, corporate finance, treasury operations, investment services, and capital market intermediary activities and portfolio management. The Bank also provides privatization, M&A, debt and equity issues and asset purchases and sales services and strategic consultancy. Its subsidiaries include TSKB Real Estate Appraisal Company, TSKB Real Estate Investment Company, TSKB Investment Trust, and Yatirim Finansman Securities. In February 2013, the Company sold its 1.43% stake in Is Yatirim Ortakligi AS to Is Yatirim Menkul Degerler AS.
Türkiye Sinai Kalkinma Bankasi AS engages in the provision of corporate, investment and advisory services. The company is headquartered in Istanbul, Istanbul Province. The service range covers corporate lending and project finance, corporate finance, treasury operations, investment services, and capital market intermediary activities and portfolio management. The Bank also provides privatization, M&A, debt and equity issues and asset purchases and sales services and strategic consultancy. Its subsidiaries include TSKB Real Estate Appraisal Company, TSKB Real Estate Investment Company, TSKB Investment Trust, and Yatirim Finansman Securities. In February 2013, the Company sold its 1.43% stake in Is Yatirim Ortakligi AS to Is Yatirim Menkul Degerler AS.
Profitability: TSKB delivered strong results with net income of TRY 3.4 billion for the quarter, up 47% year-on-year and 9% quarter-on-quarter, and a sector-leading return on equity of 31.3%.
Asset Quality: The bank’s NPL ratio fell below 1% to 0.9%, with no new NPL inflow for a fifth consecutive quarter and continued strong collections from previously problematic loans.
Loan Growth: Real FX-adjusted loan growth reached 4.5% in the first half, tracking in line with year-end guidance.
NIM Performance: Net interest margin stayed robust and flat at 5.7% QoQ, already exceeding year-end guidance and benefiting from proactive balance sheet management.
Funding & Liquidity: Three new DFI loan agreements worth about $305 million were signed, supporting a strong funding and liquidity position.
Fee & Commission Income: Fee and commission income contracted 45% YoY, with muted corporate finance activity and a high base effect from last year.
Cost Dynamics: Operating expenses rose nearly 60% YoY, partly due to 75th anniversary and HR-related one-offs, with cost-to-income ratio remaining low at 16.2%.
Sustainability: The bank continued to advance its sustainability strategy, with SDG-linked loans accounting for 93% of the portfolio and significant progress toward climate and recovery targets.